Efficacy of tumor necrosis factor ? and eicosanoid inhibitors in experimental models of neonatal sepsis
- 1 June 1994
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 9 (1) , 49-54
- https://doi.org/10.1111/j.1574-695x.1994.tb00473.x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Group BStreptococcusInduces Tumor Necrosis Factor in Neonatal Piglets: Effect of the Tumor Necrosis Factor Inhibitor Pentoxifylline on Hemodynamics and Gas ExchangeAmerican Review of Respiratory Disease, 1991
- Prostanoid inhibition and group B hemolytic streptococci (GBS) induced neutropenia in newborn pigletsProstaglandins, Leukotrienes & Essential Fatty Acids, 1990
- Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheepJournal of Applied Physiology, 1989
- Tumor Necrosis Factor Causes Increased Pulmonary Permeability and Edema: Comparison to Septic Acute Lung InjuryAmerican Review of Respiratory Disease, 1988
- Prostanoids in neonates with persistent pulmonary hypertensionThe Journal of Pediatrics, 1987
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Group B Streptococcal Infection in NewbornsNew England Journal of Medicine, 1986
- Effects of Cyclooxygenase Inhibition on the Response to Group B Streptococcal Toxin in SheepPediatric Research, 1983
- Studies on Group B β-Hemolytic Streptococcus. II. Effects on Pulmonary Hemodynamics and Vascular Permeability in Unanesthetized SheepPediatric Research, 1981